 | • レポートコード：MRC2-11QY04461 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はレイノー現象管理のグローバル市場について調査・分析したレポートです。種類別（ベータ遮断薬、プロラクチン阻害薬、カルシニューリン阻害薬、抗生物質、抗リウマチ薬、抗リウマチ薬、狭心症薬、血管拡張薬）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別レイノー現象管理の競争状況、市場シェア ・世界のレイノー現象管理市場：種類別市場規模 2015年-2020年（ベータ遮断薬、プロラクチン阻害薬、カルシニューリン阻害薬、抗生物質、抗リウマチ薬、抗リウマチ薬、狭心症薬、血管拡張薬） ・世界のレイノー現象管理市場：種類別市場規模予測 2021年-2026年（ベータ遮断薬、プロラクチン阻害薬、カルシニューリン阻害薬、抗生物質、抗リウマチ薬、抗リウマチ薬、狭心症薬、血管拡張薬） ・世界のレイノー現象管理市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、Eコマース） ・世界のレイノー現象管理市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、Eコマース） ・北米のレイノー現象管理市場分析：米国、カナダ ・ヨーロッパのレイノー現象管理市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのレイノー現象管理市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のレイノー現象管理市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのレイノー現象管理市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi-Aventis、GlaxoSmithKline、TEVA Pharmaceuticals Industries、Mylan、Sandoz、Unichempharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Raynaud’s phenomenon is a medical condition in which spasm of arteries cause episodes of reduced blood flow.
North America dominates the global market of Raynaud’s phenomenon management owing to the presence of reimbursement scenario and skilled professionals.
Market Analysis and Insights: Global Raynaud’s Phenomenon Management Market
The global Raynaud’s Phenomenon Management market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Raynaud’s Phenomenon Management Scope and Market Size
Raynaud’s Phenomenon Management market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Raynaud’s Phenomenon Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi-Aventis
GlaxoSmithKline
TEVA Pharmaceuticals Industries
Mylan
Sandoz
Unichempharma
…
Market segment by Type, the product can be split into
Beta-Blockers
Prolactin Inhibitors
Calcineurin Inhibitors
Antibiotics
Antimigraine Agents
Antirheumatics
Antianginal Agents
Vasodilators
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Store
E-Commerce
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Raynaud’s Phenomenon Management Revenue
1.4 Market by Type
1.4.1 Global Raynaud’s Phenomenon Management Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Beta-Blockers
1.4.3 Prolactin Inhibitors
1.4.4 Calcineurin Inhibitors
1.4.5 Antibiotics
1.4.6 Antimigraine Agents
1.4.7 Antirheumatics
1.4.8 Antianginal Agents
1.4.9 Vasodilators
1.5 Market by Application
1.5.1 Global Raynaud’s Phenomenon Management Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Store
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Raynaud’s Phenomenon Management Market Perspective (2015-2026)
2.2 Global Raynaud’s Phenomenon Management Growth Trends by Regions
2.2.1 Raynaud’s Phenomenon Management Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Raynaud’s Phenomenon Management Historic Market Share by Regions (2015-2020)
2.2.3 Raynaud’s Phenomenon Management Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Raynaud’s Phenomenon Management Market Growth Strategy
2.3.6 Primary Interviews with Key Raynaud’s Phenomenon Management Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Raynaud’s Phenomenon Management Players by Market Size
3.1.1 Global Top Raynaud’s Phenomenon Management Players by Revenue (2015-2020)
3.1.2 Global Raynaud’s Phenomenon Management Revenue Market Share by Players (2015-2020)
3.1.3 Global Raynaud’s Phenomenon Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Raynaud’s Phenomenon Management Market Concentration Ratio
3.2.1 Global Raynaud’s Phenomenon Management Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Raynaud’s Phenomenon Management Revenue in 2019
3.3 Raynaud’s Phenomenon Management Key Players Head office and Area Served
3.4 Key Players Raynaud’s Phenomenon Management Product Solution and Service
3.5 Date of Enter into Raynaud’s Phenomenon Management Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Raynaud’s Phenomenon Management Historic Market Size by Type (2015-2020)
4.2 Global Raynaud’s Phenomenon Management Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
5.2 Global Raynaud’s Phenomenon Management Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Raynaud’s Phenomenon Management Market Size (2015-2020)
6.2 Raynaud’s Phenomenon Management Key Players in North America (2019-2020)
6.3 North America Raynaud’s Phenomenon Management Market Size by Type (2015-2020)
6.4 North America Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
7 Europe
7.1 Europe Raynaud’s Phenomenon Management Market Size (2015-2020)
7.2 Raynaud’s Phenomenon Management Key Players in Europe (2019-2020)
7.3 Europe Raynaud’s Phenomenon Management Market Size by Type (2015-2020)
7.4 Europe Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
8 China
8.1 China Raynaud’s Phenomenon Management Market Size (2015-2020)
8.2 Raynaud’s Phenomenon Management Key Players in China (2019-2020)
8.3 China Raynaud’s Phenomenon Management Market Size by Type (2015-2020)
8.4 China Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
9 Japan
9.1 Japan Raynaud’s Phenomenon Management Market Size (2015-2020)
9.2 Raynaud’s Phenomenon Management Key Players in Japan (2019-2020)
9.3 Japan Raynaud’s Phenomenon Management Market Size by Type (2015-2020)
9.4 Japan Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Raynaud’s Phenomenon Management Market Size (2015-2020)
10.2 Raynaud’s Phenomenon Management Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Raynaud’s Phenomenon Management Market Size by Type (2015-2020)
10.4 Southeast Asia Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
11 India
11.1 India Raynaud’s Phenomenon Management Market Size (2015-2020)
11.2 Raynaud’s Phenomenon Management Key Players in India (2019-2020)
11.3 India Raynaud’s Phenomenon Management Market Size by Type (2015-2020)
11.4 India Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Raynaud’s Phenomenon Management Market Size (2015-2020)
12.2 Raynaud’s Phenomenon Management Key Players in Central & South America (2019-2020)
12.3 Central & South America Raynaud’s Phenomenon Management Market Size by Type (2015-2020)
12.4 Central & South America Raynaud’s Phenomenon Management Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi-Aventis
13.1.1 Sanofi-Aventis Company Details
13.1.2 Sanofi-Aventis Business Overview
13.1.3 Sanofi-Aventis Raynaud’s Phenomenon Management Introduction
13.1.4 Sanofi-Aventis Revenue in Raynaud’s Phenomenon Management Business (2015-2020))
13.1.5 Sanofi-Aventis Recent Development
13.2 GlaxoSmithKline
13.2.1 GlaxoSmithKline Company Details
13.2.2 GlaxoSmithKline Business Overview
13.2.3 GlaxoSmithKline Raynaud’s Phenomenon Management Introduction
13.2.4 GlaxoSmithKline Revenue in Raynaud’s Phenomenon Management Business (2015-2020)
13.2.5 GlaxoSmithKline Recent Development
13.3 TEVA Pharmaceuticals Industries
13.3.1 TEVA Pharmaceuticals Industries Company Details
13.3.2 TEVA Pharmaceuticals Industries Business Overview
13.3.3 TEVA Pharmaceuticals Industries Raynaud’s Phenomenon Management Introduction
13.3.4 TEVA Pharmaceuticals Industries Revenue in Raynaud’s Phenomenon Management Business (2015-2020)
13.3.5 TEVA Pharmaceuticals Industries Recent Development
13.4 Mylan
13.4.1 Mylan Company Details
13.4.2 Mylan Business Overview
13.4.3 Mylan Raynaud’s Phenomenon Management Introduction
13.4.4 Mylan Revenue in Raynaud’s Phenomenon Management Business (2015-2020)
13.4.5 Mylan Recent Development
13.5 Sandoz
13.5.1 Sandoz Company Details
13.5.2 Sandoz Business Overview
13.5.3 Sandoz Raynaud’s Phenomenon Management Introduction
13.5.4 Sandoz Revenue in Raynaud’s Phenomenon Management Business (2015-2020)
13.5.5 Sandoz Recent Development
13.6 Unichempharma
13.6.1 Unichempharma Company Details
13.6.2 Unichempharma Business Overview
13.6.3 Unichempharma Raynaud’s Phenomenon Management Introduction
13.6.4 Unichempharma Revenue in Raynaud’s Phenomenon Management Business (2015-2020)
13.6.5 Unichempharma Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Raynaud’s Phenomenon Management Key Market Segments
Table 2. Key Players Covered: Ranking by Raynaud’s Phenomenon Management Revenue
Table 3. Ranking of Global Top Raynaud’s Phenomenon Management Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Raynaud’s Phenomenon Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Beta-Blockers
Table 6. Key Players of Prolactin Inhibitors
Table 7. Key Players of Calcineurin Inhibitors
Table 8. Key Players of Antibiotics
Table 9. Key Players of Antimigraine Agents
Table 10. Key Players of Antirheumatics
Table 11. Key Players of Antianginal Agents
Table 12. Key Players of Vasodilators
Table 13. Global Raynaud’s Phenomenon Management Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Raynaud’s Phenomenon Management Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Raynaud’s Phenomenon Management Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Raynaud’s Phenomenon Management Market Share by Regions (2015-2020)
Table 17. Global Raynaud’s Phenomenon Management Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Raynaud’s Phenomenon Management Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Raynaud’s Phenomenon Management Market Growth Strategy
Table 23. Main Points Interviewed from Key Raynaud’s Phenomenon Management Players
Table 24. Global Raynaud’s Phenomenon Management Revenue by Players (2015-2020) (Million US$)
Table 25. Global Raynaud’s Phenomenon Management Market Share by Players (2015-2020)
Table 26. Global Top Raynaud’s Phenomenon Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Raynaud’s Phenomenon Management as of 2019)
Table 27. Global Raynaud’s Phenomenon Management by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Raynaud’s Phenomenon Management Product Solution and Service
Table 30. Date of Enter into Raynaud’s Phenomenon Management Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 33. Global Raynaud’s Phenomenon Management Market Size Share by Type (2015-2020)
Table 34. Global Raynaud’s Phenomenon Management Revenue Market Share by Type (2021-2026)
Table 35. Global Raynaud’s Phenomenon Management Market Size Share by Application (2015-2020)
Table 36. Global Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 37. Global Raynaud’s Phenomenon Management Market Size Share by Application (2021-2026)
Table 38. North America Key Players Raynaud’s Phenomenon Management Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Raynaud’s Phenomenon Management Market Share (2019-2020)
Table 40. North America Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 41. North America Raynaud’s Phenomenon Management Market Share by Type (2015-2020)
Table 42. North America Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 43. North America Raynaud’s Phenomenon Management Market Share by Application (2015-2020)
Table 44. Europe Key Players Raynaud’s Phenomenon Management Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Raynaud’s Phenomenon Management Market Share (2019-2020)
Table 46. Europe Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Raynaud’s Phenomenon Management Market Share by Type (2015-2020)
Table 48. Europe Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Raynaud’s Phenomenon Management Market Share by Application (2015-2020)
Table 50. China Key Players Raynaud’s Phenomenon Management Revenue (2019-2020) (Million US$)
Table 51. China Key Players Raynaud’s Phenomenon Management Market Share (2019-2020)
Table 52. China Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 53. China Raynaud’s Phenomenon Management Market Share by Type (2015-2020)
Table 54. China Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 55. China Raynaud’s Phenomenon Management Market Share by Application (2015-2020)
Table 56. Japan Key Players Raynaud’s Phenomenon Management Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Raynaud’s Phenomenon Management Market Share (2019-2020)
Table 58. Japan Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Raynaud’s Phenomenon Management Market Share by Type (2015-2020)
Table 60. Japan Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Raynaud’s Phenomenon Management Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Raynaud’s Phenomenon Management Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Raynaud’s Phenomenon Management Market Share (2019-2020)
Table 64. Southeast Asia Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Raynaud’s Phenomenon Management Market Share by Type (2015-2020)
Table 66. Southeast Asia Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Raynaud’s Phenomenon Management Market Share by Application (2015-2020)
Table 68. India Key Players Raynaud’s Phenomenon Management Revenue (2019-2020) (Million US$)
Table 69. India Key Players Raynaud’s Phenomenon Management Market Share (2019-2020)
Table 70. India Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 71. India Raynaud’s Phenomenon Management Market Share by Type (2015-2020)
Table 72. India Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 73. India Raynaud’s Phenomenon Management Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Raynaud’s Phenomenon Management Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Raynaud’s Phenomenon Management Market Share (2019-2020)
Table 76. Central & South America Raynaud’s Phenomenon Management Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Raynaud’s Phenomenon Management Market Share by Type (2015-2020)
Table 78. Central & South America Raynaud’s Phenomenon Management Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Raynaud’s Phenomenon Management Market Share by Application (2015-2020)
Table 80. Sanofi-Aventis Company Details
Table 81. Sanofi-Aventis Business Overview
Table 82. Sanofi-Aventis Product
Table 83. Sanofi-Aventis Revenue in Raynaud’s Phenomenon Management Business (2015-2020) (Million US$)
Table 84. Sanofi-Aventis Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Revenue in Raynaud’s Phenomenon Management Business (2015-2020) (Million US$)
Table 89. GlaxoSmithKline Recent Development
Table 90. TEVA Pharmaceuticals Industries Company Details
Table 91. TEVA Pharmaceuticals Industries Business Overview
Table 92. TEVA Pharmaceuticals Industries Product
Table 93. TEVA Pharmaceuticals Industries Revenue in Raynaud’s Phenomenon Management Business (2015-2020) (Million US$)
Table 94. TEVA Pharmaceuticals Industries Recent Development
Table 95. Mylan Company Details
Table 96. Mylan Business Overview
Table 97. Mylan Product
Table 98. Mylan Revenue in Raynaud’s Phenomenon Management Business (2015-2020) (Million US$)
Table 99. Mylan Recent Development
Table 100. Sandoz Company Details
Table 101. Sandoz Business Overview
Table 102. Sandoz Product
Table 103. Sandoz Revenue in Raynaud’s Phenomenon Management Business (2015-2020) (Million US$)
Table 104. Sandoz Recent Development
Table 105. Unichempharma Company Details
Table 106. Unichempharma Business Overview
Table 107. Unichempharma Product
Table 108. Unichempharma Revenue in Raynaud’s Phenomenon Management Business (2015-2020) (Million US$)
Table 109. Unichempharma Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Raynaud’s Phenomenon Management Market Share by Type: 2020 VS 2026
Figure 2. Beta-Blockers Features
Figure 3. Prolactin Inhibitors Features
Figure 4. Calcineurin Inhibitors Features
Figure 5. Antibiotics Features
Figure 6. Antimigraine Agents Features
Figure 7. Antirheumatics Features
Figure 8. Antianginal Agents Features
Figure 9. Vasodilators Features
Figure 10. Global Raynaud’s Phenomenon Management Market Share by Application: 2020 VS 2026
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Drug Store Case Studies
Figure 14. E-Commerce Case Studies
Figure 15. Raynaud’s Phenomenon Management Report Years Considered
Figure 16. Global Raynaud’s Phenomenon Management Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Raynaud’s Phenomenon Management Market Share by Regions: 2020 VS 2026
Figure 18. Global Raynaud’s Phenomenon Management Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Raynaud’s Phenomenon Management Market Share by Players in 2019
Figure 21. Global Top Raynaud’s Phenomenon Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Raynaud’s Phenomenon Management as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Raynaud’s Phenomenon Management Revenue in 2019
Figure 23. North America Raynaud’s Phenomenon Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Raynaud’s Phenomenon Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Raynaud’s Phenomenon Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Raynaud’s Phenomenon Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Raynaud’s Phenomenon Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Raynaud’s Phenomenon Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Raynaud’s Phenomenon Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
疼痛管理治療薬の世界市場（～2026年） Market Analysis and Insights: Global Pain Management Therapeutics Market The global Pain Management Therapeutics market size is projected to reach US$ 59160 million by 2026, from US$ 57740 million in 2020, at a CAGR of 2.3%% during 2021-2026. Global Pain Management Therapeutics Scope and Market Size…- カルチノイド症候群管理の世界市場（～2026年） Carcinoid syndrome comprises of signs and symptoms including flushing of the face, debilitating diarrhea, asthma caused due to vasoconstriction, intestinal bleeding, fast heartbeat, shortness of breath, sweating, unexplained weight gain etc. which are settled secondary to carcinoid tumor. The manage…
- 網膜色素変性症治療・管理の世界市場（～2026年） Retinitis pigmentosa (RP) is a genetic disorder of the eyes that causes loss of vision. Retinitis pigmentosa is generally inherited from a person's parents. Mutations in one of more than 50 genes is involved. Market Analysis and Insights: Global Retinitis Pigmentosa Treatment & Management Market The…
- 製品情報管理の世界市場：種類別（ソリューション、サービス）、導入別（オンプレミス、クラウド）、エンドユーザー産業別、地域別分析 The Product information management market is expected to grow significantly at a CAGR of 25% during the forecast period (2018-2023). The scope includes different Deployment modes of product information management market, such as on cloud. The regions considered under the scope of the report include …
- 倉庫管理におけるIoTの世界市場（～2026年） The Internet of Things (IoT) is the network of physical devices, vehicles, home appliances, and other items embedded with electronics, software, sensors, actuators, and connectivity which enables these things to connect and exchange data, creating opportunities for more direct integration of the phy…